Source: Cureus. Unidades: FZEA, FMRP
Subjects: CORONAVIRUS, COVID-19, ANTI-HELMÍNTICOS, PREVENÇÃO DE DOENÇAS
ABNT
KERR, Lucy et al. Ivermectin prophylaxis used for COVID-19: a citywide, prospective, observational study of 223,128 subjects using propensity score matching. Cureus, v. 14, n. 1, p. 1-25, 2022Tradução . . Disponível em: https://doi.org/10.7759/cureus.21272. Acesso em: 01 dez. 2025.APA
Kerr, L., Cadegiani, F. A., Baldi, F., Lôbo, R. B., Assagra, W. L. O., Proença, F. C., et al. (2022). Ivermectin prophylaxis used for COVID-19: a citywide, prospective, observational study of 223,128 subjects using propensity score matching. Cureus, 14( 1), 1-25. doi:10.7759/cureus.21272NLM
Kerr L, Cadegiani FA, Baldi F, Lôbo RB, Assagra WLO, Proença FC, Kory P, Hibberd JA, Chamie-Quintero JJ. Ivermectin prophylaxis used for COVID-19: a citywide, prospective, observational study of 223,128 subjects using propensity score matching [Internet]. Cureus. 2022 ; 14( 1): 1-25.[citado 2025 dez. 01 ] Available from: https://doi.org/10.7759/cureus.21272Vancouver
Kerr L, Cadegiani FA, Baldi F, Lôbo RB, Assagra WLO, Proença FC, Kory P, Hibberd JA, Chamie-Quintero JJ. Ivermectin prophylaxis used for COVID-19: a citywide, prospective, observational study of 223,128 subjects using propensity score matching [Internet]. Cureus. 2022 ; 14( 1): 1-25.[citado 2025 dez. 01 ] Available from: https://doi.org/10.7759/cureus.21272
